Reuters logo
5 years ago
BRIEF-Catalyst Pharma drops in premarket after mid-stage results of study delayed
September 26, 2012 / 12:56 PM / 5 years ago

BRIEF-Catalyst Pharma drops in premarket after mid-stage results of study delayed

NEW YORK, Sept 26 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 18.5 percent to $1.50 in premarket after mid-stage results of cocaine addicition study delayed

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below